OBJECTIVE: To construct a mania rating scale designed for children and adolescents. METHODS: Fourteen questions from the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present Episode (K-SADS-P) 1986 version plus a new item assessing mood lability were used to construct a clinician-rated mania rating scale (K-SADS-MRS). Interrater reliability was determined prospectively with 22 patients from a bipolar outpatient clinic. Sensitivity to treatment effects was determined in a separate cohort of 23 patients. RESULTS: Internal consistency (Cronbach's alpha = 0.94) and interrater reliability (intraclass correlation coefficient = 0.97 between two raters) were high. Convergent validity with the Clinical Global Impressions-Severity scale (bipolar version) was good (r(s)= 0.91, p < 0.001). Treatment responders had significantly greater reduction in K-SADS-MRS scores than nonresponders (-15.6 +/- 8.7 vs. 0.3 +/- 8.8), t(21) = 4.2, p < 0.001. The K-SADS-MRS scores differentiated bipolar patients who had clinically significant manic symptoms from those who did not, with a sensitivity of 87% and a specificity of 81%. CONCLUSION: The K-SADS-MRS shows promise as a rating scale for measuring manic symptom severity in pediatric bipolar patients.
OBJECTIVE: To construct a mania rating scale designed for children and adolescents. METHODS: Fourteen questions from the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present Episode (K-SADS-P) 1986 version plus a new item assessing mood lability were used to construct a clinician-rated mania rating scale (K-SADS-MRS). Interrater reliability was determined prospectively with 22 patients from a bipolar outpatient clinic. Sensitivity to treatment effects was determined in a separate cohort of 23 patients. RESULTS: Internal consistency (Cronbach's alpha = 0.94) and interrater reliability (intraclass correlation coefficient = 0.97 between two raters) were high. Convergent validity with the Clinical Global Impressions-Severity scale (bipolar version) was good (r(s)= 0.91, p < 0.001). Treatment responders had significantly greater reduction in K-SADS-MRS scores than nonresponders (-15.6 +/- 8.7 vs. 0.3 +/- 8.8), t(21) = 4.2, p < 0.001. The K-SADS-MRS scores differentiated bipolar patients who had clinically significant manic symptoms from those who did not, with a sensitivity of 87% and a specificity of 81%. CONCLUSION: The K-SADS-MRS shows promise as a rating scale for measuring manic symptom severity in pediatric bipolarpatients.
Authors: Sarah Horwitz; Christine Demeter; Margaret Hayden; Amy Storfer-Isser; Thomas W Frazier; Mary A Fristad; L Eugene Arnold; Eric A Youngstrom; Boris Birmaher; David Axelson; Robert L Findling Journal: Psychiatr Serv Date: 2012-08 Impact factor: 3.084
Authors: Eric A Youngstrom; Jennifer Kogos Youngstrom; Andrew J Freeman; Andres De Los Reyes; Norah C Feeny; Robert L Findling Journal: J Child Adolesc Psychopharmacol Date: 2011-10 Impact factor: 2.576
Authors: Danella M Hafeman; Genna Bebko; Michele A Bertocci; Jay C Fournier; Lisa Bonar; Susan B Perlman; Michael Travis; Mary Kay Gill; Vaibhav A Diwadkar; Jeffrey L Sunshine; Scott K Holland; Robert A Kowatch; Boris Birmaher; David Axelson; Sarah M Horwitz; L Eugene Arnold; Mary A Fristad; Thomas W Frazier; Eric A Youngstrom; Robert L Findling; Wayne Drevets; Mary L Phillips Journal: J Psychiatr Res Date: 2014-08-08 Impact factor: 4.791
Authors: Alissa J Ellis; Larissa C Portnoff; David A Axelson; Robert A Kowatch; Patricia Walshaw; David J Miklowitz Journal: Psychiatry Res Date: 2014-02-18 Impact factor: 3.222
Authors: Genna Bebko; Michele A Bertocci; Jay C Fournier; Amanda K Hinze; Lisa Bonar; Jorge R C Almeida; Susan B Perlman; Amelia Versace; Claudiu Schirda; Michael Travis; Mary Kay Gill; Christine Demeter; Vaibhav A Diwadkar; Gary Ciuffetelli; Eric Rodriguez; Thomas Olino; Erika Forbes; Jeffrey L Sunshine; Scott K Holland; Robert A Kowatch; Boris Birmaher; David Axelson; Sarah M Horwitz; L Eugene Arnold; Mary A Fristad; Eric A Youngstrom; Robert L Findling; Mary L Phillips Journal: JAMA Psychiatry Date: 2014-01 Impact factor: 21.596
Authors: David J Miklowitz; Elizabeth L George; David A Axelson; Eunice Y Kim; Boris Birmaher; Christopher Schneck; Carol Beresford; W Edward Craighead; David A Brent Journal: J Affect Disord Date: 2004-10 Impact factor: 4.839
Authors: Danella Hafeman; Genna Bebko; Michele A Bertocci; Jay C Fournier; Henry W Chase; Lisa Bonar; Susan B Perlman; Michael Travis; Mary Kay Gill; Vaibhav A Diwadkar; Jeffrey L Sunshine; Scott K Holland; Robert A Kowatch; Boris Birmaher; David Axelson; Sarah M Horwitz; L Eugene Arnold; Mary A Fristad; Thomas W Frazier; Eric A Youngstrom; Robert L Findling; Mary L Phillips Journal: J Affect Disord Date: 2016-10-11 Impact factor: 4.839
Authors: Boris Birmaher; John A Merranko; Tina R Goldstein; Mary Kay Gill; Benjamin I Goldstein; Heather Hower; Shirley Yen; Danella Hafeman; Michael Strober; Rasim S Diler; David Axelson; Neal D Ryan; Martin B Keller Journal: J Am Acad Child Adolesc Psychiatry Date: 2018-08-07 Impact factor: 8.829
Authors: Soledad Romero; Boris Birmaher; David A Axelson; Ana-Maria Iosif; Douglas E Williamson; Mary Kay Gill; Benjamin I Goldstein; Michael A Strober; Jeffrey Hunt; Tina R Goldstein; Christianne Esposito-Smythers; Satish Iyengar; Neal D Ryan; Martin Keller Journal: J Clin Psychiatry Date: 2009-10 Impact factor: 4.384